% Expired Patents = 75.0

Forward Citations = 34

Loading Chart...

4 inventors (with patents filed for the assignee):

Alfred M Ajami (4 out of 8 patents)

David O Barlow (2 out of 2 patents)

Mitchell P Fink (1 out of 15 patents)

4. Carrie A Sims (1 out of 1 patent)

4 patents: Sort by Forward Citations

1. 6989390 - Amonafide salts (2006-01-24),

2. 6846842 - Pyruvate ester composition and method of use for resuscitation after events of ischemia and reperfusion (2005-01-25),

3. 6693198 - Amonafide salts (2004-02-17),

4. 6610270 - In vivo determination of metabolic function for use in therapy management (2003-08-26),

Xanthus Life Sciences, Inc. is a leading biotechnology company specializing in the discovery and development of innovative therapies for various diseases. With a focus on precision medicine, Xanthus is dedicated to improving patient outcomes through cutting-edge research and personalized treatment options. Our team of experts is committed to advancing healthcare through groundbreaking science and transformative technologies.

Profile summary based on public USPTO records.

Company Badge

USPTO Data Jan 1 1976 - Sep 29 2026

4 Patents

#411 in Cambridge, MA

#3,308 in Massachusetts

#60,561 in US

Cambridge, MA, United States of America

Xanthus Life Sciences, Inc.

Forward Citations = 34

4 inventors:

Alfred M Ajami (4 out of 8 patents)

David O Barlow (2 out of 2 patents)

Mitchell P Fink (1 out of 15 patents)

4. Carrie A Sims (1 out of 1 patent)

Please report any incorrect information to [email protected]